253 related articles for article (PubMed ID: 15152283)
1. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy.
Devlin SM; Swain MG; Urbanski SJ; Burak KW
Can J Gastroenterol; 2004 May; 18(5):321-6. PubMed ID: 15152283
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.
Yu ZJ; Zhang LL; Huang TT; Zhu JS; He ZB
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):873-877. PubMed ID: 31150366
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
[TBL] [Abstract][Full Text] [Related]
4. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.
Hlivko JT; Shiffman ML; Stravitz RT; Luketic VA; Sanyal AJ; Fuchs M; Sterling RK
Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1036-40. PubMed ID: 18586559
[TBL] [Abstract][Full Text] [Related]
5. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
Chatur N; Ramji A; Bain VG; Ma MM; Marotta PJ; Ghent CN; Lilly LB; Heathcote EJ; Deschenes M; Lee SS; Steinbrecher UP; Yoshida EM
Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421
[TBL] [Abstract][Full Text] [Related]
6. Use of sirolimus in the treatment of refractory autoimmune hepatitis.
Chatrath H; Allen L; Boyer TD
Am J Med; 2014 Nov; 127(11):1128-1131. PubMed ID: 24979741
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
Richardson PD; James PD; Ryder SD
J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy.
Sharzehi K; Huang MA; Schreibman IR; Brown KA
Can J Gastroenterol; 2010 Oct; 24(10):588-92. PubMed ID: 21037986
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil for autoimmune hepatitis: a single practice experience.
Wolf DC; Bojito L; Facciuto M; Lebovics E
Dig Dis Sci; 2009 Nov; 54(11):2519-22. PubMed ID: 19082888
[TBL] [Abstract][Full Text] [Related]
10. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
Brunt EM; Di Bisceglie AM
Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334
[TBL] [Abstract][Full Text] [Related]
11. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.
Czaja AJ; Carpenter HA
J Clin Gastroenterol; 2005 Oct; 39(9):819-25. PubMed ID: 16145346
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil as second line therapy in autoimmune hepatitis?
Hennes EM; Oo YH; Schramm C; Denzer U; Buggisch P; Wiegard C; Kanzler S; Schuchmann M; Boecher W; Galle PR; Adams DH; Lohse AW
Am J Gastroenterol; 2008 Dec; 103(12):3063-70. PubMed ID: 18853972
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.
Zachou K; Gatselis N; Papadamou G; Rigopoulou EI; Dalekos GN
J Hepatol; 2011 Sep; 55(3):636-646. PubMed ID: 21238519
[TBL] [Abstract][Full Text] [Related]
14. A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.
Zachou K; Gatselis NK; Arvaniti P; Gabeta S; Rigopoulou EI; Koukoulis GK; Dalekos GN
Aliment Pharmacol Ther; 2016 May; 43(10):1035-47. PubMed ID: 26991238
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.
Park SW; Um SH; Lee HA; Kim SH; Sim Y; Yim SY; Seo YS; Ryu HS
Clin Mol Hepatol; 2016 Jun; 22(2):281-5. PubMed ID: 27246353
[TBL] [Abstract][Full Text] [Related]
16. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
Fallatah HI; Akbar HO
Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):517-22. PubMed ID: 21780898
[TBL] [Abstract][Full Text] [Related]
18. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.
Baven-Pronk AM; Coenraad MJ; van Buuren HR; de Man RA; van Erpecum KJ; Lamers MM; Drenth JP; van den Berg AP; Beuers UH; den Ouden J; Koek GH; van Nieuwkerk CM; Bouma G; Brouwer JT; van Hoek B
Aliment Pharmacol Ther; 2011 Aug; 34(3):335-43. PubMed ID: 21668459
[TBL] [Abstract][Full Text] [Related]
19. Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use.
Ytting H; Larsen FS
Scand J Gastroenterol; 2015 Aug; 50(8):1025-31. PubMed ID: 25862144
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up.
Aw MM; Dhawan A; Samyn M; Bargiota A; Mieli-Vergani G
J Hepatol; 2009 Jul; 51(1):156-60. PubMed ID: 19446911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
